About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,041 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,041 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3441-3460 of 4,041 trials

CompletedLCC-CARIS-01: Molecular Profiling in Gynaecological CancerThis is a pilot feasibility study assessing the use of a commercial molecular profiling service in the UK's National Health Service (NHS).NCT02668913·Leeds, West Yorkshire RecruitingSurvival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinomaOvarian carcinoma is the most lethal gynecological malignancy. Epithelial ovarian carcinoma is the gynecological malignancy with the highest mortality rate.NCT07540403·Rome UnknownPhase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in HumansThe primary objective of the trial is to test the new radio tracer 68Ga-NODAGA-E\[c(RGDyK)\]2 for PET imaging of angiogenesis.NCT02970786·Copenhagen

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

CompletedDetermination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian CancerBOVARY-Pilot is a monocentric prospective transversal pilot study with a total duration of 6 months.NCT03881683·Vandœuvre-lès-Nancy

TerminatedA Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung CancersThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-EVS459 and the safety and imaging properties of…NCT06376253·Tel Aviv

RecruitingAdministration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic CancerBackground: A person s tumor is studied for mutations.NCT03412877·Bethesda, Maryland

CompletedOvarian Cancer Patient Questionnaire on Genetic TestingThe objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of…NCT00486707·Houston, Texas

CompletedEGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis phase I trial studies the side effects and the best dose of giving EGEN-001 together with pegylated liposomal doxorubicin hydrochloride in treating patients with ovarian…NCT01489371·Birmingham, Alabama and 6 others

CompletedPreoperative Care In Ovarian Cancer PatientsA randomised controlled trial study consisting of two-group pretest-post-test.NCT04260334·Izmir

CompletedAmifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsRATIONALE: Amifostine may be effective in reducing pain, numbness, tingling, and other symptoms of peripheral neuropathy.NCT00078845·Decatur, Illinois and 14 others

RecruitingA Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesATLAS-101 is a Phase I/II clinical trial of AMXI-5001 in adult participants with advanced malignancies who have previously failed other therapies. The study has two phases.NCT04503265·Los Angeles, California and 3 others

Active not recruitingPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis phase II/III trial studies how well pegylated liposomal doxorubicin hydrochloride with atezolizumab and/or bevacizumab work in treating patients with ovarian, fallopian tube…NCT02839707·Anchorage, Alaska and 918 others

CompletedSunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian CancerThis phase II trial studies the side effects of sunitinib malate and how well it works in treating patients with ovarian cancer that is persistent or has come back.NCT00979992·Birmingham, Alabama and 96 others

CompletedHER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung CancerRATIONALE: Vaccines made from the HER2/neu antigen may make the body build an immune response and kill tumor cells.NCT00003002·Seattle, Washington

UnknownA Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsThis is a phase I clinical study to evaluate the safety and tolerability of CAR-T in patients with CD70-positive advanced/metastatic solid tumors, and to obtain the maximum…NCT05420545·Jinan, Shandong

CompletedTopotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003967·Iowa City, Iowa and 5 others

CompletedA Study LY2228820 for Recurrent Ovarian CancerA study for women with ovarian cancer that has returned at least 6 months after platinum-based chemotherapy.NCT01663857·Phoenix, Arizona and 29 others

UnknownBlood Test for Ovarian Cancer Associated Auto AntibodiesIntend of use: A blood test for Cancer Associated Antibodies (CAAA) is an aid in initial diagnosis of ovarian cancer in women with suspected ovarian pathology as detected by…NCT01334437·Haifa

CompletedAvatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis phase II trial studies how well Avatar-directed chemotherapy works in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that does not respond to…NCT02312245·Phoenix, Arizona and 2 others

RecruitingBP1001-A in Patients With Advanced or Recurrent Solid TumorsThis is a phase I, open-label, study of BP1001-A in participants with advanced or recurrent solid tumors.NCT04196257·Silver Spring, Maryland and 3 others

PreviousPage 173 of 203Next